Lovastatin
Who holds supplier records for Lovastatin? 8 organisations hold a current record for Lovastatin: an active US FDA Type II Drug Master File or a CEP. A further 16 organisations have only historical (inactive) DMF filings. 3 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: China (3), India (2), Netherlands (1) and United States (1); not recorded for 1.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Lovastatin: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/lovastatin
Reading the evidence
- 8 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 3 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (8)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Lovastatin. Country is the organisation's recorded country, not necessarily the manufacturing site.
- Chongqing Daxin Pharmaceutical Co., Ltd.ChinaActive DMF 20061, 35431, 12496 · latest filing Dec 2020
- TAPI NL BVNetherlandsCEPActive DMF 11502 · latest filing May 1995
- CONCORD BIOTECH LTDIndia Company GMP cert on recordActive DMF 17393 · latest filing May 2004
- Livzon Group (Ningxia) Pharmaceutical Co.,Ltd.ChinaActive DMF 18539 · latest filing Jul 2005
- Lupin LimitedIndia Company GMP cert on recordActive DMF 17353, 17310 · latest filing Apr 2004
- STERLING BIOTECH LTDUnited StatesCEPActive DMF 24859 · latest filing Apr 2011
- Zhejiang Apeloa Kangyu Pharmaceutical Co., Ltd.ChinaActive DMF 19217 · latest filing Mar 2006
- KREBS BIOCHEMICALS AND INDUSTRIES LTDCEP Company GMP cert on record
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (3)
Certificates of Suitability on the EDQM register for Lovastatin, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 12 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| STERLING BIOTECH LIMITED Vadodara | IN | CEP 2014-146 - Rev 01 Lovastatin | Jul 2026 | — |
| TAPI NL B.V. Amsterdam | NL | CEP 2000-406 - Rev 06 Lovastatin | Jul 2025 | — |
| KREBS BIOCHEMICALS & INDUSTRIES LIMITED Kothapalli | IN | R1-CEP 2004-026 - Rev 03 Lovastatin | Aug 2023 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (16)
Organisations whose Type II DMFs for Lovastatin are no longer active. These show a past filing, not current supply.
Show all 16 historical records
- ALEMBIC LTDInactive DMF 28058 · filed Mar 2014
- China · Inactive DMF 18188, 12400 · filed Mar 2005
- Slovenia · Inactive DMF 17662 · filed Sept 2004
- CHUNGHWA CHEMICAL SYNTHESIS AND BIOTECH CO LTDInactive DMF 17498 · filed Jun 2004
- KREBS BIOCHEMICALS INDUSTRIES LTDInactive DMF 17174 · filed Feb 2004
- Spain · Inactive DMF 17069 · filed Jan 2004
- ERCROS INDUSTRIAL SA FYSEInactive DMF 16901 · filed Oct 2003
- India · Inactive DMF 14912 · filed Jun 2000
- South · Inactive DMF 14921 · filed May 2000
- Italy · Inactive DMF 14784, 13917 · filed Mar 2000
- RANBAXY LABORATORIES LTDInactive DMF 14470 · filed Oct 1999
- YUNG SHIN PHARMACEUTICAL INDUSTRIES CO LTDInactive DMF 14049 · filed Mar 1999
- ABBOTT LABORATORIES CHEMICAL AND AGRICULTURAL PRODUCTS DIVInactive DMF 13248 · filed Sept 1998
- Taiwan · Inactive DMF 12481 · filed Apr 1997
- ANTIBIOTIC COInactive DMF 11336 · filed Dec 1996
- China · Inactive DMF 12133 · filed Sept 1996
Overview
Lovastatin is a member of the drug class known as statins, which are used to reduce blood cholesterol levels. It works by inhibiting the enzyme HMG-CoA reductase, which plays a central role in the production of cholesterol in the liver.
Chemical identity
- IUPAC name
- [(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] (2S)-2-methylbutanoate
- Canonical SMILES
- CC[C@H](C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C
- InChIKey
- PCZOHLXUXFIOCF-BXMDZJJMSA-N
- Synonyms
- Mevacor API, 6.alpha.-methylcompactin, advicor component lovastatin, altoprev, c10aa02, l-154803, mevacor, mevinacor, mevinolin, mevlor, mk-803, monacolin k
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- HMG-CoA Reductase Inhibitor
- Mechanism of action
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Lovastatin?
8 organisations hold an active US FDA Type II Drug Master File or a CEP for Lovastatin: Chongqing Daxin Pharmaceutical Co., Ltd. (China), TAPI NL BV (Netherlands), CONCORD BIOTECH LTD (India), Livzon Group (Ningxia) Pharmaceutical Co.,Ltd. (China), Lupin Limited (India), STERLING BIOTECH LTD (United States), Zhejiang Apeloa Kangyu Pharmaceutical Co., Ltd. (China) and KREBS BIOCHEMICALS AND INDUSTRIES LTD. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Lovastatin Drug Master Files are active?
Chongqing Daxin Pharmaceutical Co., Ltd. (DMF 20061, 35431), TAPI NL BV (DMF 11502), CONCORD BIOTECH LTD (DMF 17393), Livzon Group (Ningxia) Pharmaceutical Co.,Ltd. (DMF 18539), Lupin Limited (DMF 17353, 17310), STERLING BIOTECH LTD (DMF 24859) and Zhejiang Apeloa Kangyu Pharmaceutical Co., Ltd. (DMF 19217). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Lovastatin records mean?
16 organisations have only inactive Type II DMFs for Lovastatin. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Lovastatin have a European Certificate of Suitability?
Yes. 3 organisations hold a valid CEP for Lovastatin on the EDQM register, including STERLING BIOTECH LIMITED Vadodara (IN), TAPI NL B.V. Amsterdam (NL) and KREBS BIOCHEMICALS & INDUSTRIES LIMITED Kothapalli (IN). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Lovastatin supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Lovastatin?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.